Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATBPF | AZN | AMGN | GILD | BMY |
| Company | Antibe Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.2328 | 184.36 | 326.03 | 130.44 | 57.65 |
| High | 0.2452 | 185.19 | 326.79 | 133.10 | 58.00 |
| Low | 0.1889 | 182.80 | 321.92 | 130.00 | 56.93 |
| Latest | 0.2156 | 183.46 | 323.85 | 132.69 | 57.38 |
| Change | +0.0256 | -1.28 | -5.97 | +1.04 | -0.84 |
| % Change | +13.47% | -0.69% | -1.81% | +0.79% | -1.44% |
| Volume | 33,900 | 1,170,100 | 3,481,300 | 5,880,700 | 9,447,300 |
| 20-Day Average Volume | 41,625 | 2,017,955 | 2,623,835 | 5,441,390 | 9,923,435 |
| Previous Close | 0.1900 | 184.74 | 329.82 | 131.65 | 58.22 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2805 | 195.77 | 345.10 | 135.20 | 58.65 |
| 20-Day Raw Stochastic | 40.74% | 6.77% | 5.14% | 32.94% | 11.69% |
| 20-Day Relative Strength | 34.47 | 38.46 | 35.77 | 43.28 | 45.88 |
| Weighted Alpha | +1.76 | +28.03 | +14.91 | +29.11 | +23.98 |
| Today's Opinion | 56% Sell | 24% Buy | 24% Sell | 8% Buy | 24% Buy |
| Previous Opinion | 56% Sell | 24% Buy | 8% Sell | 8% Buy | 40% Buy |
| Last Month's Opinion | 8% Sell | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +86.99% since 04/01/24 | -2.16% since 04/27/26 | -4.80% since 04/27/26 | +3.87% since 04/27/26 | -0.69% since 04/27/26 |
| Low | 0.1113 on 04/02/24 | 181.73 on 04/29/26 | 321.92 on 05/04/26 | 127.96 on 04/30/26 | 56.93 on 05/04/26 |
| High | 0.2452 on 04/08/24 | 190.00 on 04/30/26 | 349.54 on 04/30/26 | 133.10 on 05/04/26 | 60.78 on 04/30/26 |
| 1-Month | |||||
| %Chg | -36.00% since 03/08/24 | -9.84% since 04/02/26 | -6.92% since 04/02/26 | -5.02% since 04/02/26 | -3.72% since 04/02/26 |
| Low | 0.1113 on 04/02/24 | 181.73 on 04/29/26 | 321.92 on 05/04/26 | 127.64 on 04/27/26 | 56.93 on 05/04/26 |
| High | 0.3582 on 03/13/24 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -74.24% since 01/08/24 | -2.13% since 02/04/26 | -11.56% since 02/04/26 | -9.26% since 02/04/26 | -0.42% since 02/04/26 |
| Low | 0.1113 on 04/02/24 | 181.73 on 04/29/26 | 321.92 on 05/04/26 | 127.64 on 04/27/26 | 56.45 on 03/24/26 |
| High | 0.8122 on 01/09/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -35.64% since 10/04/23 | +11.82% since 11/04/25 | +9.15% since 11/04/25 | +7.88% since 11/04/25 | +25.86% since 11/04/25 |
| Low | 0.1113 on 04/02/24 | 162.04 on 11/05/25 | 302.13 on 11/05/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 0.8855 on 11/09/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,423 | 286,514,752 | 177,998,896 | 163,406,864 | 118,869,808 |
| Shares Outstanding, K | 52,981 | 1,550,908 | 539,685 | 1,241,222 | 2,041,735 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -14,730,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -3,090,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.51 | 0.26 | 0.44 | 0.32 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 02/14/24 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 1.86 on 02/10/26 | 1.58 on 04/30/26 |
| Earnings Date | 07/04/24 | 08/04/26 | 08/04/26 | 05/07/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.23 | 15.67 | 16.05 | 10.22 |